期刊文献+

磁共振动态增强扫描定量分析方法评价肺部肿块良恶性初步研究 被引量:16

A preliminary study of diagnosing lung neoplasms with quantitative analysis of DCE-MRI
下载PDF
导出
摘要 目的:探讨动态增强磁共振(DCE-MRI)扫描定量参数测定对鉴别肺部肿块良恶性的可行性。方法:77例肺部肿块患者行3.0T MR动态增强扫描,并经手术或穿刺活检病理证实,测量定量参数:容量转移常数(K^(trans))、速率常数(K_(ep))和血管外细胞外间隙容积比(v_e),分别对良性病变、恶性病变定量参数值进行统计学分析;最后绘制ROC曲线。结果 :恶性病变组:低分化腺癌K^(trans)、K_(ep)、v_e均值分别为(0.270±0.089)min^(-1)、(0.926±0.475)min^(-1)、0.340±0.144,低分化鳞癌分别为(0.268±0.066)min^(-1)、(0.997±0.464)min^(-1)、0.293±0.091,小细胞癌均值为(0.238±0.074)min^(-1)、(0.617±0.369)min^(-1)、0.412±0.312;良性病变组K^(trans)、K_(ep)、v_e均值分别为(0.190±0.084)min^(-1)、(0.569±0271)min^(-1)、0.392±0.207。良、组行独立样本t检验,K^(trans)、K_(ep)值均有统计学差异(P值均<0.05),v_e值无统计学差异(P值>0.05),良性病灶组分别与低分化腺癌、低分化鳞癌组行成组设计方差分析,K^(trans)及K_(ep)差异均有统计学意义(P值均<0.05),v_e均无统计学差异(P值均>0.05);低分化腺癌与低分化鳞癌K^(trans)、K_(ep)、v_e差异均无统计学意义(P值均>0.05)。良性病灶组及恶性病灶组ROC曲线下面积分别为0.741、0.715,敏感性分别为88.4%、39.5%;特异性分别为54.2%、95.8%。结论 :DCE-MRI定量参数K^(trans)、K_(ep)值鉴别诊断肺部肿块具有可行性,有助于对肺癌及肺部良性病灶进行鉴别。 Objective: To investigate the feasibility of quantitative analysis parameters of dynamic contrast-enhanced MRI (DCE-MRI) in diagnosis of lung neoplasms and assess the differences of quantitative MR pharmacokinetic parameters volume transfer constant(Ktrans), exchange rate constant(Kep) and extravascular extracellular volume fraction(ve) in lung neoplasms. Methods: Three Tesla MR examinations were performed in 77 patients confirmed by biopsy and the quantitative MR pharmaeokinetic parameters including Ktrans, Kep and ve were obtained. Independent two sample t test was used between benign and malignant lung lesions. Finally, the areas under the ROC curve(AUC) of Ktrans, Kep and ve between malignant and benign lesions were compared. Results: The mean Ktrans, Kep and ve of poorly differentiated adenocarcinoma(n=26) were(0.270±0.089) min-1, (0.926±0.475) min-1 and (0.340±0.144). The mean Ktrans, Kep and ve of poorly differentiated squamous cell carcinoma(n=13) were (0.268±0.066) min-1, (0.997±0.464) min-1 and (0.293±0.091). The mean Ktrans, Kep and ve of small-cell lung cancer were (0.238±0.074) min-1, (0.617±0.369) min-1 and (0.412±0.312). The mean Ktrans, Kep and ve of benign lesions(n=24) were (0.190±0.084) min-1, (0.569±0.271) min-1 and (0.392±0.207). There was significant difference between malignant and benign lesions in either Ktrans or Kep(t=3.697, 3.883, respectively, P〈0.05). There was no significant difference between malignant and benign lesions in ve(t=1.341, P〉0.05). Ktrans and Kep values of benign lesions were significantly lower than those of squamous cell carcinoma and adenocarcinoma(both P〈0.05). No significant difference was observed between squamous cell carcinoma and adenocarcinoma in Ktrans or Kep(both P〉0.05). The AUCs of Ktrans and Kep between malignant and benign lesions were 0.741 and 0.715. The sensitivity of Ktrans and Kep were 88.4% and 39.5%, and the specificity of K
出处 《中国临床医学影像杂志》 北大核心 2017年第7期475-479,共5页 Journal of China Clinic Medical Imaging
关键词 肺肿瘤 活组织检查 针吸 磁共振成像 Lung neoplasms Biopsy, needle Magnetic resonance imaging
  • 相关文献

参考文献1

二级参考文献16

  • 1Alonzi R,Padhani AR,Allen C.Dynamic contrast enhanced MRI in prostate cancer.Eur J Radiol,2007,63:335-350. 被引量:1
  • 2Schlemmer HP,Merkle J,Grobholz R,et al.Can pre-operative contrast-enhanced dynamic MR imaging for prostate cancer predict microvessel density in prostatectomy specimens.Eur Radiol,2004,14:309-317. 被引量:1
  • 3Langer DL,der Kwast TH,Evans AJ,et al.Prostate cancer detection with multi-parametric MRI:logistic regression analysis of quantitative T2,diffusion-weighted imaging,and dynamic contrast-enhanced MRI.J Magn Reson Imaging,2009,30:327 -334. 被引量:1
  • 4Padhani AR,Gapinski CJ,Macvicar DA,et al.Dynamic contrast enhanced MRI of prostate cancer:correlation with morphology and tumour stage,histological grade and PSA.Clin Radiol,2000,55:99-109. 被引量:1
  • 5Buckley DL,Roberts C,Parker GJ,et al.Prostate cancer:evaluation of vascular characteristics with dynamic contrastenhanced T1 -weighted MR imaging:initial experience.Radiology,2004,233:709-715. 被引量:1
  • 6Tofts PS,Brix G,Buckley DL,et al.Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer:standardized quantities and symbols.J Magn Reson Imaging,1999,10:223-232. 被引量:1
  • 7Tofts PS,Kermode AG.Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging.1.Fundamental concepts.Magn Reson Med,1991,17:357-367. 被引量:1
  • 8van DFA,der Graaf MV,Engelbrecht MR,et al.Combined quantitative dynamic contrast-enhanced MR imaging and (1) H MR spectroscopic imaging of human prostate cancer.J Magn Reson Imaging,2004,20:279-287. 被引量:1
  • 9Kozlowski P,Chang SD,Jones EC,et al.Combined diffusionweighted and dynamic contrast-enhanced MRI for prostate cancer diagnosis:correlation with biopsy and histopathology.J Magn Reson Imaging,2006,24:108-113. 被引量:1
  • 10Jackson AS,Reinsberg SA,Sohaib SA,et al.Dynamic contrastenhanced MRI for prostate cancer localization.Br J Radiol,2009,82:148-156. 被引量:1

共引文献46

同被引文献141

引证文献16

二级引证文献53

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部